Compare Cronos Group Inc (CRON) vs Schlumberger NV (SLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Schlumberger NV — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.20B), while Schlumberger NV trades at $48.98 (market cap $71.18B). The key difference: Schlumberger NV is far larger — about 59.3× Cronos Group Inc's market cap, and Schlumberger NV pays a 2.46% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Schlumberger NV for 99 Days on average.
| CRON | SLB | |
|---|---|---|
Market Cap | $1.20B | $71.18B |
Volume | 450,387 | 14,872,321 |
Sector | Health | Energy |
52-Week High | $3.55 | $60.10 |
52-Week Low | $2.30 | $31.72 |
Typical Hold Time | 22 Days | 99 Days |
Enterprise Value | $401.73M | $79.91B |
Dividend Yield | — | 2.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 1.98% on the day, amid a bearish technical signal. The company reported mixed quarterly earnings but achieved record revenue and gross profit in Q2 2026, with net income turning positive. Recent investor day highlighted international expansion and cash flow focus. Valuation ratios show a P/E of 17.11 and P/S of 6.91, with strong net income margin of 39.08% projected for 2026.
Outlook is cautiously optimistic, driven by revenue growth and profitability improvements, but risks include cash flow volatility and competitive pressures. Analyst consensus is mixed with 60% hold rating. The stock's near-term performance hinges on execution of expansion plans and sustained earnings momentum.
SLB trades at $48.98, down 2.04% with bearish technical signals despite strong analyst support. The company maintains solid profitability with 8.53% net margin and 13.37% ROE, though recent revenue and earnings show slight contraction. Recent contract wins in Saudi Arabia, Oman, and Mozambique provide multi-year revenue visibility and expansion in key energy markets.
Wall Street remains bullish with 85% buy ratings and $64.58 price target implying 32% upside. However, declining profit margins and bearish technical indicators suggest near-term pressure. The stock offers value at current levels for investors comfortable with energy sector volatility and execution risks on new contracts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Schlumberger NV
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →
